Search

everythinglearnresearchcommunity

for

Search:↓

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Some cancer treatments can cause permanent hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Some chemotherapy can cause permanent hair loss.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.